TOI

THE ONCOLOGY INSTITUTE, INC.

TOI · CIK 1799191 · Annual (10-K) · Last 5 years

Financial Trends

Revenue$393M
20202024
Net Income−$65M
20202024
Operating CF$4M
20202024
Free Cash Flow$0M
20202024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.4B$0.3B$0.3B$0.2B—
Cost of Revenue—————
Gross Profit—————
R&D Expense—————
SG&A Expense$0.1B$0.1B$0.1B$0.1B—
Operating Income$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B
Net Income$-0.1B$-0.1B$0.0B$-0.0B$-0.0B
EPS (Basic)$-0.71$-0.92$0.00$-0.16—
EPS (Diluted)$-0.71$-0.92$-0.21$-0.16—

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.2B$0.2B$0.3B$0.2B$0.2B
Current Assets$0.1B$0.1B$0.1B$0.2B$0.0B
Cash & Equivalents————$0.0B
Total Liabilities$0.2B$0.2B$0.1B$0.1B$0.0B
Current Liabilities$0.1B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.1B$0.1B$0.1B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$0.0B$-0.0B$-0.1B$-0.0B$-0.0B
Investing Cash Flow$0.0B$0.1B$-0.1B$-0.0B$-0.2B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B—
Financing Cash Flow$-0.0B$-0.0B$0.1B$0.2B$0.2B
← Companies